Universitätsklinikum Heidelberg
The University Hospital Heidelberg is one of the major healthcare centers in Germany. Our objective is the development of innovative diagnostics and therapies as well as their quick implementation for the patient. With about 14,000 employees in more than 50 specialized clinical departments with almost 2,500 beds, about 80,000 patients in part-time and full-time inpatient treatment as well as 1,000,000 patients in ambulant treatment are medicated each year.
Postdoc - Molecular Biology Research in AML (f/m/d)
wanted of the next possible date for the Department of Hematology, Oncology and Rheumatology in the research group of Prof. Carsten Müller-Tidow.
The Department of Internal Medicine V of Heidelberg University Hospital is a leading center for research in Hematology and Oncology. The location of Heidelberg offers state-of-the-art infrastructure in a highly collaborative environment (NCT, DKFZ and EMBL Heidelberg).
The work of our research group focuses on stem cells and therapy resistance. We aim to understand how epigenetic dysregulation participates in the pathogenesis and chemoresistance of AML. To follow this question a broad number of in-vitro- and in-vivo-models are investigated. The final aim of our studies is to translate the experimental findings into novel treatment strategies for AML patients at diagnosis and relapse.
More about the research group: http://lab.mueller-tidow.de
Note: The UKHD is subject to the provisions of the Infektionsschutzgesetz. Therefore, a valid measles immunity certificate is required for all persons employed at the UKHD.
The UKHD embraces diversity and values diversity.
Regardless of age, gender, sexual identity, disability, origin or religion, we offer everyone the same opportunities. If one gender is underrepresented in a particular area, we place particular emphasis on counteracting this imbalance. If they have the same aptitude, qualifications and professional performance, we give priority to people with severe disabilities when considering them for vacancies.
Classification is based on qualifications and personal requirements. The salary (gross) is for a full-time position and does not include the annual bonus or other allowances.
For further information please contact Prof. Carsten Müller-Tidow or Annette Becker (scientific coordinator) via e-mail or phone.
Interested?
Applications will be accepted until 10.01.2026 direct online.
Klinik für Hämatologie, Onkologie und Rheumatologie
Prof. Carsten Müller-Tidow
Im Neuenheimer Feld 410
69120 Heidelberg
| Veröffentlicht | vor 4 Tagen |
| Läuft ab | in 26 Tagen |
| Arbeitsmodus | Full Time |
| Quelle |
Die Stille ist ohrenbetäubend. Sie senden Bewerbung nach Bewerbung, aber Ihr Posteingang bleibt leer. Unsere KI enthüllt die verborgenen Barrieren, die Sie für Recruiter unsichtbar machen.
Keine Angebote gefunden, versuchen Sie, Ihre Suchkriterien zu ändern.